IS3787A7 - Aðferð til framleiðslu nýrra lyfjaforma, sem innihalda jónanleg, lyfjafræðilega virk efni - Google Patents

Aðferð til framleiðslu nýrra lyfjaforma, sem innihalda jónanleg, lyfjafræðilega virk efni

Info

Publication number
IS3787A7
IS3787A7 IS3787A IS3787A IS3787A7 IS 3787 A7 IS3787 A7 IS 3787A7 IS 3787 A IS3787 A IS 3787A IS 3787 A IS3787 A IS 3787A IS 3787 A7 IS3787 A7 IS 3787A7
Authority
IS
Iceland
Prior art keywords
manufacture
active substances
pharmaceutically active
pharmaceutical forms
forms containing
Prior art date
Application number
IS3787A
Other languages
English (en)
Other versions
IS1749B (is
Inventor
Magnus Lindstedt Bengt
Johan Gunnar Lundberg Per
Original Assignee
Aktiebolaget Astra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aktiebolaget Astra filed Critical Aktiebolaget Astra
Publication of IS3787A7 publication Critical patent/IS3787A7/is
Publication of IS1749B publication Critical patent/IS1749B/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
IS3787A 1990-12-07 1991-12-06 Aðferð til framleiðslu nýrra lyfjaforma, sem innihalda jónanleg, lyfjafræðilega virk efni IS1749B (is)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9003903A SE9003903D0 (sv) 1990-12-07 1990-12-07 New pharmaceutical formulations

Publications (2)

Publication Number Publication Date
IS3787A7 true IS3787A7 (is) 1992-06-08
IS1749B IS1749B (is) 2000-07-11

Family

ID=20381122

Family Applications (1)

Application Number Title Priority Date Filing Date
IS3787A IS1749B (is) 1990-12-07 1991-12-06 Aðferð til framleiðslu nýrra lyfjaforma, sem innihalda jónanleg, lyfjafræðilega virk efni

Country Status (17)

Country Link
US (2) US5707656A (is)
EP (1) EP0560816B1 (is)
JP (1) JP3276956B2 (is)
AT (1) ATE444737T1 (is)
AU (1) AU656346B2 (is)
CA (1) CA2097176C (is)
DE (1) DE69133623D1 (is)
EE (1) EE03105B1 (is)
FI (1) FI932553A (is)
HU (1) HU218661B (is)
IE (1) IE914136A1 (is)
IS (1) IS1749B (is)
NO (1) NO305536B1 (is)
PT (1) PT99720B (is)
SE (1) SE9003903D0 (is)
WO (1) WO1992010171A1 (is)
YU (1) YU186791A (is)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT946145E (pt) * 1996-12-20 2008-10-17 Mcneil Ppc Inc Fármacos antitússicos libertados por resinas de troca iónica
US20030118641A1 (en) * 2000-07-27 2003-06-26 Roxane Laboratories, Inc. Abuse-resistant sustained-release opioid formulation
JP2003522127A (ja) * 1999-07-29 2003-07-22 ロクセニ ラボラトリーズ インコーポレイテッド オピオイド徐放性製剤
AU2002320309B2 (en) * 2001-07-06 2007-07-12 Endo Pharmaceuticals, Inc. Oxymorphone controlled release formulations
EP1429728A1 (en) * 2001-08-29 2004-06-23 SRL Technologies, Inc. Sustained release preparations
EP1499295A4 (en) * 2002-04-05 2006-04-05 Penwest Pharmaceuticals Co EXTENDED RELEASE METOPROLOL FORMULATIONS
US7314640B2 (en) * 2003-07-11 2008-01-01 Mongkol Sriwongjanya Formulation and process for drug loaded cores
US20050265955A1 (en) * 2004-05-28 2005-12-01 Mallinckrodt Inc. Sustained release preparations
JP2006296511A (ja) * 2005-04-15 2006-11-02 Transcutaneous Technologies Inc 外用剤、外用剤の塗布方法、イオントフォレーシス装置及び経皮パッチ
JP2006346368A (ja) * 2005-06-20 2006-12-28 Transcutaneous Technologies Inc イオントフォレーシス装置及びその製造方法
EP1905433A1 (en) * 2005-07-15 2008-04-02 Transcu Ltd. Percutaneous absorption patch with application position indicating function, and iontophoresis device
JP2007037868A (ja) * 2005-08-05 2007-02-15 Transcutaneous Technologies Inc 経皮投与装置及びその制御方法
US8386030B2 (en) * 2005-08-08 2013-02-26 Tti Ellebeau, Inc. Iontophoresis device
US20070060860A1 (en) * 2005-08-18 2007-03-15 Transcutaneous Technologies Inc. Iontophoresis device
JPWO2007026671A1 (ja) * 2005-08-29 2009-03-05 Ｔｔｉ・エルビュー株式会社 センサからの情報により投与すべき薬剤の選定を行うイオントフォレーシス装置
AU2006289888B2 (en) * 2005-09-16 2010-12-02 Tti Ellebeau, Inc. Catheter type iontophoresis apparatus
US20070071807A1 (en) * 2005-09-28 2007-03-29 Hidero Akiyama Capsule-type drug-releasing device and capsule-type drug-releasing device system
WO2007038028A1 (en) * 2005-09-28 2007-04-05 Tti Ellebeau, Inc. Iontophoresis apparatus and method to deliver active agents to biological interfaces
EP1941929A1 (en) * 2005-09-30 2008-07-09 Tti Ellebeau, Inc. Electrode structure for iontophoresis comprising shape memory separator, and iontophoresis apparatus comprising the same
US20090187134A1 (en) * 2005-09-30 2009-07-23 Hidero Akiyama Iontophoresis Device Controlling Amounts of a Sleep-Inducing Agent and a Stimulant to be Administered and Time at Which the Drugs are Administered
KR20080058438A (ko) * 2005-09-30 2008-06-25 티티아이 엘뷰 가부시키가이샤 생물학적 계면들로 다중 활성 약제들을 전달하기 위한이온삼투 장치
US20070197955A1 (en) * 2005-10-12 2007-08-23 Transcutaneous Technologies Inc. Mucous membrane adhesion-type iontophoresis device
US20080193514A1 (en) * 2006-11-02 2008-08-14 Transcu Ltd. Compostions and methods for iontophoresis delivery of active ingredients through hair follicles
EP2123259A1 (en) * 2007-01-16 2009-11-25 Hokkaido University Liposome preparation for iontophoresis having antioxidant component encapsulated therein
JP2010187707A (ja) * 2007-06-12 2010-09-02 Hokkaido Univ インスリンを封入したイオントフォレーシス用リポソーム製剤
TW201026347A (en) * 2008-09-10 2010-07-16 Transcu Ltd Apparatus and method to dispense HPC-based viscous liquids into porous substrates, e. g., continuous web-based process
EP2413898A1 (en) 2009-04-03 2012-02-08 Coating Place, Inc. Modified-release pharmaceutical drug composition

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4983392A (en) * 1983-11-14 1991-01-08 Bio-Mimetics, Inc. Bioadhesive compositions and methods of treatment therewith
US4692462A (en) * 1985-03-18 1987-09-08 Menley & James Laboratories, Ltd. Compositions and method of controlling transdermal penetration of topical and systemic agents
EP0199855A1 (en) * 1985-05-02 1986-11-05 Gist-Brocades N.V. Tablets comprising tromethoprim and a sulfonamide
JPS62223112A (ja) * 1986-03-25 1987-10-01 Rooto Seiyaku Kk 歯周病治療剤
IE62100B1 (en) * 1986-07-30 1994-12-14 Fisons Corp Coated ion exchange resins
DE3740684A1 (de) * 1987-12-01 1989-06-15 Woehr Otto Gmbh Parksystem
MC2025A1 (fr) * 1988-04-20 1990-04-25 Asta Pharma Ag Medicament contenant de l'azelastine et capable de liberer celle-ci de facon controlee
IL90245A (en) * 1988-05-11 1994-04-12 Glaxo Group Ltd Resin adsorption containing ranitidine together with synthetic resin replaces cations, its preparation and pharmaceutical preparations containing it
CA2002492A1 (en) * 1988-11-11 1990-05-11 Sandra T. A. Malkowska Pharmaceutical ion exchange resin composition
US5149523A (en) * 1989-06-20 1992-09-22 Aktiebolaget Hassle Polystyrenesulfonate-drug complex and solid dosage forms thereof

Also Published As

Publication number Publication date
AU8930591A (en) 1992-07-08
US5709882A (en) 1998-01-20
PT99720B (pt) 2002-04-29
HUT64213A (en) 1993-12-28
EE03105B1 (et) 1998-08-17
EP0560816B1 (en) 2009-10-07
NO932053L (no) 1993-07-20
JP3276956B2 (ja) 2002-04-22
PT99720A (pt) 1992-10-30
YU186791A (sh) 1994-04-05
EP0560816A1 (en) 1993-09-22
HU218661B (hu) 2000-10-28
DE69133623D1 (de) 2009-11-19
CA2097176A1 (en) 1992-06-08
IS1749B (is) 2000-07-11
NO305536B1 (no) 1999-06-21
IE914136A1 (en) 1992-06-17
HU9301671D0 (en) 1993-09-28
ATE444737T1 (de) 2009-10-15
JPH06503311A (ja) 1994-04-14
US5707656A (en) 1998-01-13
WO1992010171A1 (en) 1992-06-25
FI932553A0 (fi) 1993-06-04
CA2097176C (en) 2002-03-26
AU656346B2 (en) 1995-02-02
FI932553A (fi) 1993-06-04
NO932053D0 (no) 1993-06-04
SE9003903D0 (sv) 1990-12-07

Similar Documents

Publication Publication Date Title
IS3787A7 (is) Aðferð til framleiðslu nýrra lyfjaforma, sem innihalda jónanleg, lyfjafræðilega virk efni
MY105279A (en) Transdermal therapeutic system comprising tulobuterol as active substance.
NO851170L (no) Lagringsstabile, hurtignedbrytende farmasoeytiske virksomme stoff-presslegemer
ATE240344T1 (de) Nor-pregnane zur induzierung hypothalamischer effekte
DE69034226D1 (de) Herstellungsverfahren von Huperzine A und deren Analogen und Verbindungen nützlich dazu
DK324687A (da) Transdermalt farmeceutisk praeparat
DK0957981T3 (da) Rersorvoirer til aflevering af lægemidler ved elektrotransport, indeholdende inerte fyldmaterialer
SE8901003D0 (sv) Snabbloesliga preparat
HU9301672D0 (en) Method for manufacturing solid dosing forms of medicaments with controlled releasing of active agents
ATE254851T1 (de) Iod-herstellungszusammensetzung
ATE222499T1 (de) Pharmazeutische zusammensetzung enthaltend einen embryonalen extrakt und verfahren zu ihrer herstellung
SE9902742D0 (sv) New pharmaceutical formultion
DE59607949D1 (de) Feste arzneimittelform mit polymerem material verteiltem wirkstoff
ES469749A1 (es) Un procedimiento para la preparacion de una formulacion far-maceutica de una droga de notroimidazol.
BR9813037A (pt) Composto, processo para sua preparação, uso do mesmo, preparação farmacêutica, e, combinação desta com pelo menos uma outra substância ativa
CO4370014A1 (es) Soluciones inyectables estables de diritromicina
ES8304924A1 (es) Un procedimiento para la preparacion de nuevos derivados del acido glutamil-diaminopimelico que contiene una b-lactama.
JPS5414389A (en) Production of amphoteric ion exchange composite membrane
RS49796B (sr) UPOTREBA SOLI 3α, 7α-DIHIDROKSI-12-KETO-5β-HOLANSKE KISELINE KAO AKTIVNE SUPSTANCE ZA IZRADU LEKOVA ZA LEČENJE DIJABETESA
UA22221A (uk) Лікарська форма протипухлиhhого препарату hа осhові похідhого пластиhи (ii) з поліаhіоhом дезоксирибоhуклеїhової кислоти
MX9600856A (es) Preparacion farmaceutica de unidades multiples, que contienen un inhibidor de la bomba de protones.
RU97111373A (ru) Способ лечения заболеваний вирусной этиологии
RU98113272A (ru) Способ приготовления лекарственных препаратов